![INDIAN PHARMA UNDER USFDA LENS INDIAN PHARMA UNDER USFDA LENS](https://magarticles.magzter.com/articles/118/408466/5e4e7e9a99586/INDIAN-PHARMAUNDERUSFDA-LENS.jpg)
In 2019, the US Food Drug Administration (FDA) issued warning letters to 19 Indian pharma giants. The number has drastically increased from 10 companies in 2018. The USFDA issues warning letters to pharma companies if the products do not meet specific regulatory requirements. The warning letter makes clear that the company must correct the problem and plan in a timeframe to inform FDA for its correction, according to USFDA.
Some of the key reasons for receiving warning letters include data integrity, insufficient documentation, misleading claims about the efficacy and risks associated with the use of a drug product, significant violations of current good manufacturing practice (CGMP) regulations for finished pharmaceuticals and Active Pharmaceutical Ingredient (APIs), commercialization of unapproved or misbranded drugs.
Indian companies are at paramount of receiving warning letters owing to the rise in an inspection by the USFDA. Sharing his views on this Sudarshan Jain, Secretary-General, Indian Pharmaceutical Alliance (IPA), Mumbai says “There is an increase in FDA inspections in India from earlier 13 percent in 2018 to 17 percent YTD 2019 of global inspections this year. This is obvious given India’s contribution to the US healthcare system as every third tablet sold in the US is from India.” The USFDA which has established its office in India in 2008 has increased its inspections. In 2017, USFDA has 147 inspections which have gone up to 192 in 2018. In 2016 the number inspections done by USFDA were 176.
“India is crucial for the US market as India has got the highest number of FDA approved manufacturing facilities. Hence, vigilance on India would always be high and any issues related to quality in the US due to Indian players will bring FDA vigilance under criticism as well”, says Prashant Khadayate – Practice Head, Healthcare, GlobalData.
This story is from the February 2020 edition of Bio Spectrum.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the February 2020 edition of Bio Spectrum.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
![Agilent releases nextgen HPLC systems with enhanced automation and sustainability capabilities Agilent releases nextgen HPLC systems with enhanced automation and sustainability capabilities](https://reseuro.magzter.com/100x125/articles/118/1916536/T3zEa8AMt1733392376858/AGILENT-RELEASES-NEXTGEN-HPLC-SYSTEMS-WITH-ENHANCED-AUTOMATION-AND-SUSTAINABILITY-CAPABILITIES.jpg)
Agilent releases nextgen HPLC systems with enhanced automation and sustainability capabilities
Agilent Technologies Inc. has announced the release of its next generation Agilent InfinityLab LC Series portfolio, which includes the 1290 Infinity III LC, 1260 Infinity III Prime LC, and 1260 Infinity III LC systems, all including the biocompatible versions.
![Univercells Technologies launches miniaturised scale-X Nexo Bioreactor Univercells Technologies launches miniaturised scale-X Nexo Bioreactor](https://reseuro.magzter.com/100x125/articles/118/1916536/sl5DzmfAu1733392338034/UNIVERCELLS-TECHNOLOGIES-LAUNCHES-MINIATURISED-SCALEX-NEXO-BIOREACTOR.jpg)
Univercells Technologies launches miniaturised scale-X Nexo Bioreactor
Univercells Technologies has announced the launch of its latest innovation, the scale-X nexo bioreactor.
![Thermo Fisher and Telangana to establish Bioprocess Design Centre for novel biotherapeutics Thermo Fisher and Telangana to establish Bioprocess Design Centre for novel biotherapeutics](https://reseuro.magzter.com/100x125/articles/118/1916536/Eu3oxbZDY1733392283988/THERMO-FISHER-AND-TELANGANA-TO-ESTABLISH-BIOPROCESS-DESIGN-CENTRE-FOR-NOVEL-BIOTHERAPEUTICS.jpg)
Thermo Fisher and Telangana to establish Bioprocess Design Centre for novel biotherapeutics
Thermo Fisher Scientific has announced the signing of a Memorandum of Understanding (MoU) with the Government of Telangana to establish a Bioprocess Design Centre (BDC) in Genome Valley, Hyderabad.
![VFL Sciences announces launch of GreatFlo Parallel Bioreactors and Fermentors VFL Sciences announces launch of GreatFlo Parallel Bioreactors and Fermentors](https://reseuro.magzter.com/100x125/articles/118/1916536/k_JwCPoFT1733392251572/VFL-SCIENCES-ANNOUNCES-LAUNCH-OF-GREATFLO-PARALLEL-BIOREACTORS-AND-FERMENTORS.jpg)
VFL Sciences announces launch of GreatFlo Parallel Bioreactors and Fermentors
Chennai-based VFL Sciences has announced the launch of GreatFlo Parallel, a range of seamlessly parallel Bioreactors and Fermentors at the IKMC 2024 event organised by IKP Knowledge Park at Hyderabad recently, by Dr Jitendra Kumar, Managing Director, BIRAC.
![Avantor opens new innovation centre for solving life science's biggest challenges Avantor opens new innovation centre for solving life science's biggest challenges](https://reseuro.magzter.com/100x125/articles/118/1916536/QNPvA-Edz1733392223797/AVANTOR-OPENS-NEW-INNOVATION-CENTRE-FOR-SOLVING-LIFE-SCIENCES-BIGGEST-CHALLENGES.jpg)
Avantor opens new innovation centre for solving life science's biggest challenges
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, has announced the opening of its new flagship Bridgewater Innovation Centre.
![Waters unveils new software to deliver lab-centric business intelligence Waters unveils new software to deliver lab-centric business intelligence](https://reseuro.magzter.com/100x125/articles/118/1916536/QqMTums8s1733392180470/WATERS-UNVEILS-NEW-SOFTWARE-TO-DELIVER-LABCENTRIC-BUSINESS-INTELLIGENCE.jpg)
Waters unveils new software to deliver lab-centric business intelligence
Waters Corporation has announced the launch of waters connect Data Intelligence software, a new cloud-based application that helps customers in regulated industries improve how they access, organise, analyse, and drive productivity from laboratory information.
![INST develops unique drug delivery method to improve treatment of brain TB INST develops unique drug delivery method to improve treatment of brain TB](https://reseuro.magzter.com/100x125/articles/118/1916536/ilPgR-THI1733392144766/INST-DEVELOPS-UNIQUE-DRUG-DELIVERY-METHOD-TO-IMPROVE-TREATMENT-OF-BRAIN-TB.jpg)
INST develops unique drug delivery method to improve treatment of brain TB
Researchers at the Institute of Nano Science and Technology (INST), Mohali, have created a unique way to deliver Tuberculosis (TB) medicines directly to the brain bypassing the challenging blood-brain barrier (BBB) that limits the effectiveness of many brain TB medicines.
![New way to create hydrogels from viral protein fragments for improving drug delivery New way to create hydrogels from viral protein fragments for improving drug delivery](https://reseuro.magzter.com/100x125/articles/118/1916536/z6L8XWDgT1733392120383/NEW-WAY-TO-CREATE-HYDROGELS-FROM-VIRAL-PROTEIN-FRAGMENTS-FOR-IMPROVING-DRUG-DELIVERY.jpg)
New way to create hydrogels from viral protein fragments for improving drug delivery
Researchers from Bose Institute, an autonomous institute of the Department of Science and Technology (DST), in Kolkata, have discovered a new way to create hydrogels using tiny protein fragments of just five amino acids from the SARS-CoV-1 virus, that could help improve targeted drug delivery & reduce side effects.
![Lupin appoints Claus Jepsen as President, Global Specialty Lupin appoints Claus Jepsen as President, Global Specialty](https://reseuro.magzter.com/100x125/articles/118/1916536/Tq3bN2QLN1733392069672/LUPIN-APPOINTS-CLAUS-JEPSEN-AS-PRESIDENT-GLOBAL-SPECIALTY.jpg)
Lupin appoints Claus Jepsen as President, Global Specialty
Global pharma major Lupin has announced the appointment of Claus Jepsen as President, Global Specialty.
![Shyamakant Giri to join as CEO of Gland Pharma Shyamakant Giri to join as CEO of Gland Pharma](https://reseuro.magzter.com/100x125/articles/118/1916536/PWRxJw3431733392047424/SHYAMAKANT-GIRI-TO-JOIN-AS-CEO-OF-GLAND-PHARMA.jpg)
Shyamakant Giri to join as CEO of Gland Pharma
Gland Pharma’s Board has approved the appointment of Shyamakant Giri, as the new Chief Executive Officer (CEO) of the company.